← Leaderboards
Sunil Krishnan
University Of Texas Hlth Sci Ctr Houston
$6,566,279
Attributed
$14,787,123
Total exposure
9
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,787,123 · 9
By mechanism
R01$8,897,217 · 4
U01$2,862,955 · 1
T32$1,809,534 · 1
R21$1,217,417 · 3
Top collaborators
- Sang Hyun Cho14 shared
- Konstantin V Sokolov10 shared
- Steven Hsesheng Lin5 shared
- Heath Devin Skinner5 shared
- Rebecca Rae Richards-Kortum3 shared
- F Avraham Dilmanian2 shared
- John G. Eley2 shared
- Jon Alexander Schwartz2 shared
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- Sang Hyun Cho$5,825,687
- Yi-Ping Li$13,186,933
- Syed H Jafri$1,347,401
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorIn VitroRadiation TherapyIn VivoRadiationGoldDoseNanotechnologyCellsResponseRadiosensitizationNeoplastic CellTranslationsInnovationMediatingToxic EffectClinically RelevantMalignant NeoplasmsRadiation ToleranceAnimalsBiologicalBiodistributionClinical TranslationChemotherapy
Grant awards (34)
Rational translation of gold nanoparticle mediated radiosensitization to the clinic$624,904
R01 · FY2025 · CA · contact PI
In situ cancer cell specific biomineralization to overcome nanoparticle delivery barriers and sensitize pancreatic cancer to radiotherapy$597,297
R01 · FY2025 · CA
In situ cancer cell specific biomineralization to overcome nanoparticle delivery barriers and sensitize pancreatic cancer to radiotherapy$567,432
R01 · FY2024 · CA
Rational translation of gold nanoparticle mediated radiosensitization to the clinic$147,082
R01 · FY2024 · CA · contact PI
Rational translation of gold nanoparticle mediated radiosensitization to the clinic$640,366
R01 · FY2023 · CA · contact PI
In situ cancer cell specific biomineralization to overcome nanoparticle delivery barriers and sensitize pancreatic cancer to radiotherapy$585,319
R01 · FY2023 · CA
Enhancing immune mediated head and neck cancer anti-tumor activity using nanoparticles$537,145
R01 · FY2023 · DE · contact PI
In situ cancer cell specific biomineralization to overcome nanoparticle delivery barriers and sensitize pancreatic cancer to radiotherapy$612,076
R01 · FY2022 · CA
Rational translation of gold nanoparticle mediated radiosensitization tothe clinic$590,750
R01 · FY2022 · CA · contact PI
Enhancing immune mediated head and neck cancer anti-tumor activity using nanoparticles$270,816
R01 · FY2022 · DE · contact PI
Rational translation of gold nanoparticle mediated radiosensitization tothe clinic$631,688
R01 · FY2021 · CA · contact PI
Enhancing Chemoradiation Efficacy through Unbiased Drug Discovery Approaches$596,334
U01 · FY2021 · CA
Enhancing immune mediated head and neck cancer anti-tumor activity using nanoparticles$518,603
R01 · FY2021 · DE · contact PI
Enhancing immune mediated head and neck cancer anti-tumor activity using nanoparticles$518,603
R01 · FY2020 · DE · contact PI
Enhancing Chemoradiation Efficacy through Unbiased Drug Discovery Approaches$495,509
U01 · FY2020 · CA
In situ cancer cell specific synthesis of gold nanoclusters for radiosensitization of pancreatic cancer$425,381
R21 · FY2020 · CA
Enhancing Chemoradiation Efficacy through Unbiased Drug Discovery Approaches$578,444
U01 · FY2019 · CA
Enhancing immune mediated head and neck cancer anti-tumor activity using nanoparticles$518,603
R01 · FY2019 · DE · contact PI
Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology$182,902
T32 · FY2019 · CA
Enhancing Chemoradiation Efficacy through Unbiased Drug Discovery Approaches$596,334
U01 · FY2018 · CA
Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology$442,787
T32 · FY2018 · CA
Enhancing Chemoradiation Efficacy through Unbiased Drug Discovery Approaches$596,334
U01 · FY2017 · CA
Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology$476,079
T32 · FY2017 · CA
Proton minibeams: Overcoming proton beams inability to spare superficial tissues$174,395
R21 · FY2017 · CA · contact PI
Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology$476,783
T32 · FY2016 · CA
Proton minibeams: Overcoming proton beams inability to spare superficial tissues$235,488
R21 · FY2016 · CA · contact PI
Radiation response modulation of tumors using biocongjugated gold nanoparticles$301,511
R01 · FY2015 · CA · contact PI
Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology$230,983
T32 · FY2015 · CA
Radiation response modulation of tumors using biocongjugated gold nanoparticles$296,563
R01 · FY2014 · CA · contact PI
Radiation response modulation of tumors using biocongjugated gold nanoparticles$291,334
R01 · FY2013 · CA · contact PI
Radiation response modulation of tumors using biocongjugated gold nanoparticles$314,182
R01 · FY2012 · CA · contact PI
Radiation response modulation of tumors using biocongjugated gold nanoparticles$332,943
R01 · FY2011 · CA · contact PI
Integrated Imaging and Photothermal Ablation of Pancreatic Cancer Resection Margi$157,528
R21 · FY2011 · CA · contact PI
Integrated Imaging and Photothermal Ablation of Pancreatic Cancer Resection Margi$224,625
R21 · FY2010 · CA · contact PI